Pegasus Biotech Inc. is a contract research organization specializing in the development of DNA vaccines and analytical testing methods for the animal and human health sectors. The company addresses the need for compliant, commercially viable biologics by providing tailored process and analytical development services that ensure efficient project execution from proof-of-concept to production.
Funding
$1.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Developing commercially viable biologics and DNA vaccines requires specialized expertise in process and analytical development, often exceeding the internal capabilities of many organizations. Ensuring compliance with global regulations throughout the development lifecycle, from initial research to technology transfer, adds further complexity and cost.
Solution
Pegasus Biotech provides contract research services specializing in process and analytical development for biologics and DNA vaccines, supporting both animal and human health sectors. The company offers tailored solutions to ensure efficient project execution, guiding clients from proof-of-concept through to compliant production. By focusing on regulatory considerations and commercial viability, Pegasus Biotech helps clients navigate the complexities of biologics development, optimizing processes and analytical methods to meet global standards.
Target Audience
The primary customers are biotechnology and biopharmaceutical companies in the animal and human health sectors seeking specialized expertise in biologics and DNA vaccine development.
Features
- Development and validation of immunoassays, molecular assays, analytical chromatography methods, and cell-based bioassays.
- Expertise in upstream and downstream process development, including media optimization and growth condition refinement.
- Support for animal health vaccine development, leveraging experience in both biopharmaceutical and animal health industries.
- Specialization in DNA vaccine development, from initial research to technology transfer.
- State-of-the-art CL1 and CL2 laboratories equipped with the latest technology.
- Flexible project structures tailored to individual client needs.
- Robust, fit-for-purpose Quality Management System (QMS) tailored for each client's needs.